Adam Waldman
Corporate Officer/Principal bei TG THERAPEUTICS, INC.
Profil
Adam Waldman is currently the Chief Commercial Officer at TG Therapeutics, Inc. He previously worked at Celgene Corp.
as the Head of Haematology & Oncology Marketing.
Waldman received an undergraduate degree from Rutgers State University of New Jersey and an MBA from the University of Rochester Simon Business School.
Aktive Positionen von Adam Waldman
| Unternehmen | Position | Beginn |
|---|---|---|
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | 04.06.2018 |
Ehemalige bekannte Positionen von Adam Waldman
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Ausbildung von Adam Waldman
| Rutgers State University of New Jersey | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
